Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
NASDAQ 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
NIKKEI 14,850.25 366.27 2.53%
TOPIX 1,214.46 26.12 2.20%
HANG SENG 22,669.68 -591.40 -2.54%

FDA Clears First Blood Glucose Monitoring System To Automatically Send Results Wirelessly Via Bluetooth® Technology to iOS



FDA Clears First Blood Glucose Monitoring System To Automatically Send Results
             Wirelessly Via Bluetooth® Technology to iOS Devices

OneTouch® Verio®Sync Meter With Mobile App Allows Patients To Easily View and
Share Blood Sugar Information Using Their iPhone®, iPad® or iPod touch®

PR Newswire

MILPITAS, Calif., March 4, 2013

MILPITAS, Calif., March 4, 2013 /PRNewswire/ -- LifeScan, Inc. announced today
that the OneTouch® Verio®Sync Blood Glucose Monitoring System has received
clearance from the US Food & Drug Administration (FDA). It is the first meter
to automatically send blood glucose results wirelessly via Bluetooth
technology to an iPhone, iPad or iPod touch using the OneTouch® Reveal™ mobile
app.  

"For so many people, their iPhone, iPad or iPod touch have become a tool of
choice to help organize and take charge of their daily lives," said Ty Lee,
Vice President of Marketing, representing the products of LifeScan, Inc. &
Animas Corp. "For people with diabetes, the new OneTouch® Verio®Sync System
will enable them to use their iOS device to view and share their blood glucose
results wirelessly, in much the same way they rely on them in other areas of
their lives."

Through the OneTouch® Reveal™ mobile app, users will be able to view a variety
of personalized information directly on their iPhone, iPad or iPod touch
including a 14-day summary of blood sugar test results, simple visuals showing
the percentage of test results within target range, and then share
that information via email or text with their care providers, family or
friends.

People with diabetes interested in learning more are encouraged to
visit www.OneTouch.com where they can sign up to receive email updates on
availability and special introductory offers for
the OneTouch® Verio®Sync System. 

About the Johnson & Johnson Family of Diabetes Companies:
LifeScan, Inc. is one of the five companies that comprise the Johnson &
Johnson Family of Diabetes Companies with the shared vision of "Creating a
world without limits for people with diabetes." Providing advanced products
and services, professional and community education, and advocacy and support
to people living with diabetes and their families, these companies include:
LifeScan, Inc., (www.OneTouch.com) a world leader in blood glucose monitoring;
Animas Corporation, (www.Animas.com) maker of innovative insulin delivery
systems; Calibra Medical, Inc., developer of a unique, wearable mealtime only
insulin patch; Children with Diabetes, Inc., (www.childrenwithdiabetes.com) a
community offering support and education for children, adults and their
families living with diabetes; and the Johnson & Johnson Diabetes Institute,
LLC, (www.JJDI.com) that empowers healthcare professionals with education and
training programs to improve the quality of life for people with diabetes.

iPhone, iPad, and iPod touch are trademarks of Apple Inc., registered in the
U.S. and other countries.
The Bluetooth^  word mark is a registered trademark owned by Bluetooth SIG,
Inc. and any use of such marks by LifeScan, Inc. is under license.

SOURCE LifeScan, Inc.

Website: http://www.OneTouch.com
Contact: Helen Patrikis or Lara Markenson, Robert Marston Marketing
Communications, Inc., +1-212-371-2200
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement